LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Collagen Matrix’s Shu-Tung Li Honored
People In The News

Collagen Matrix’s Shu-Tung Li Honored

August 31, 2012 1 min read Premium comments

Advertisement

Collagen Matrix’s Shu-Tung Li Honored
Shu-Tung Li, Ph.D.

Shu-Tung Li, Ph.D., the founder and CEO of Collagen Matrix, Inc. is the 2012 inductee into the New Jersey Inventors Hall of Fame. The award is co-sponsored by the Stevens Institute of Technology and Greenberg Traurig, LLP. The recognition is for Li’s “Patented technology related to collagen based medical implants for the repair and regeneration of soft tissue and bones.”

Li has over 40 years of experience in connective tissue research and collagen-based implant development, including 10 years of basic science research experience at the University of Connecticut Health Center. His work involved the study of the structure and function of collagen fibrils in mineralized and non-mineralized tissues.

Commenting on the award, Li said, “I believe that innovation is the backbone of economic growth and technological advancement. I am honored by this recognition.”

Li holds 30 U.S. patents, eight of which are still pending and has authored over 95 publications. He developed more than 30 collagen and mineral-based implants that are currently on the market. He was named New Jersey Executive of the Year in 2009 for his accomplishment in growing Collagen Matrix, Inc. to become one of the 50 fastest growing companies in New Jersey. The award will be presented in October 2012.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy